PIK3CA and meningioma: In detail, around 15% of skull base meningiomas have alterations in the PI3K/AKT/mTOR signaling pathway, consisting of AKT1E17K and PIK3CA mutations, in association with meningothelial histotype or brain invasion [69,74,75].